Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
Liow
K
K
Via Christi Comprehensive Epilepsy Center, University of Kansas School of Medicine-Wichita, Wichita, KS 67214-3800, USA. kliow@kumc.edu
Barkley
G L
GL
Pollard
J R
JR
Harden
C L
CL
Bazil
C W
CW
D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000592:standards*; D016568:Drugs, Generic / Q000009:adverse effects / Q000493:pharmacokinetics / Q000592:standards*; D004827:Epilepsy / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D005569:Formularies as Topic / Q000592:standards*; D007356:Insurance, Pharmaceutical Services / Q000592:standards; D010819:Physician's Role; D017009:Professional Autonomy; D012955:Societies, Medical / Q000592:standards; D013810:Therapeutic Equivalency; D014481:United States
D000927:Anticonvulsants; D016568:Drugs, Generic